Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)

Purpose Glioblastoma remains incurable despite optimal multimodal management. The interim analysis of open label, single arm INDYGO pilot trial showed actuarial 12-months progression-free survival (PFS) of 60% (median 17.1 months), actuarial 12-months overall survival (OS) of 80% (median 23.1 months...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neuro-oncology 2024-07, Vol.168 (3), p.495-505
Hauptverfasser:	Peciu-Florianu, Iulia, Vannod-Michel, Quentin, Vauleon, Enora, Bonneterre, Marie-Edith, Reyns, Nicolas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant therapy Aminolevulinic acid Glioblastoma Glioma Medicine Medicine & Public Health Neurology Oncology Patients Photodynamic therapy Quality of life Survival Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!